fig2

Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis

Figure 2. Schematic representation of the inflammatory pathway from the gut to adipose tissue and the resulting consequences on human health. LPS: Lipopolysaccharide; LBP: lipopolysaccharide binding protein; CD14: cluster of differentiation 14; NF-κB: nuclear factor kappa B.

Microbiome Research Reports
ISSN 2771-5965 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/